Verano (OTCMKTS:VRNOF – Get Rating) is one of 32 publicly-traded companies in the “Agricultural production – crops” industry, but how does it contrast to its rivals? We will compare Verano to similar companies based on the strength of its dividends, earnings, risk, profitability, valuation, institutional ownership and analyst recommendations.
This is a breakdown of current recommendations for Verano and its rivals, as provided by MarketBeat.
|Sell Ratings||Hold Ratings||Buy Ratings||Strong Buy Ratings||Rating Score|
Verano presently has a consensus target price of $26.25, indicating a potential upside of 416.73%. As a group, “Agricultural production – crops” companies have a potential upside of 85.62%. Given Verano’s stronger consensus rating and higher possible upside, equities analysts clearly believe Verano is more favorable than its rivals.
|Net Margins||Return on Equity||Return on Assets|
Insider & Institutional Ownership
28.0% of shares of all “Agricultural production – crops” companies are held by institutional investors. 20.2% of Verano shares are held by company insiders. Comparatively, 22.1% of shares of all “Agricultural production – crops” companies are held by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock will outperform the market over the long term.
Earnings & Valuation
This table compares Verano and its rivals revenue, earnings per share and valuation.
|Gross Revenue||Net Income||Price/Earnings Ratio|
|Verano Competitors||$1.63 billion||$92.76 million||0.90|
Verano’s rivals have higher revenue and earnings than Verano. Verano is trading at a lower price-to-earnings ratio than its rivals, indicating that it is currently more affordable than other companies in its industry.
Verano Company Profile
Verano Holdings Corp. operates as a vertically integrated multi-state cannabis operator in the United States. It engages in the cultivation, processing, wholesale, and retail distribution of cannabis in Arizona, Arkansas, California, Connecticut, Florida, Illinois, Maryland, Massachusetts, Michigan, Missouri, Nevada, New Jersey, Ohio, Pennsylvania, and West Virginia. The company offers artisanal cannabis products under the Encore, Avexia, MUV, and Verano brands for medical and adult-use markets. As of May 10, 2022, it operated 96 retail dispensaries, and 13 cultivation and processing facilities. The company is headquartered in Chicago, Illinois.
Receive News & Ratings for Verano Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Verano and related companies with MarketBeat.com's FREE daily email newsletter.